跳至主要内容
临床试验/NCT05690087
NCT05690087已完成不适用

Effect of Systemic Lidocaine Infusion on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Hysterectomy in Trendelenburg Position

Tanta University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2023年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
66
试验地点
1
主要终点
Optic Nerve Sheath Diameter (ONSD)

研究概览

简要总结

We hypothesize that intravenous lidocaine infusion may have beneficial effect to patients undergoing laparoscopic surgeries in Trendelenburg position by preventing ICP elevation.

详细描述

Lidocaine use, both intravenous (IV) and laryngotracheal (LT), has been reported to blunt the ICP elevations during intubation. Also, Lidocaine injected IV has been shown in models to induce cerebral vasoconstriction leading to a decrease in cerebral blood volume and thus ICP. Furthermore, IV lidocaine leads to sodium channel inhibition and thus a reduction in cerebral activity and metabolic demands, as well as excitotoxicity, leading to a potential ICP reduction effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged between 35 to 65 years
  • American society of anesthesiology (ASA) physical status I - II
  • Body mass index (BMI) between 18.5 to 28.0 kg/m2
  • Scheduled for total laparoscopic hysterectomy taking approximately 2 h with a 30° Trendelenburg position for management of uterine fibroids or refractory dysfunctional uterine bleeding.

排除标准

  • Patients with eye diseases, central nervous system diseases, cardiovascular diseases, cerebrovascular diseases or diabetes.
  • If these events occurred intraoperative:
  • Ultrasound scans or measurements failed to clearly show the structure of Optic Nerve Sheath Diameter (ONSD).
  • Surgical time less than 1 h.
  • Interruption of carbon dioxide (CO2) pneumoperitoneum and Trendelenburg position.
  • Peak airway pressure exceeding 35 cm H2O
  • Patients with a history of allergy to lidocaine.

研究组 & 干预措施

Lidocaine group

Experimental

Intravenous lidocaine 2% bolus of 1.5 mg/kg over 5 min before induction of anesthesia followed by lidocaine infusion at 1.5 mg/kg/h intraoperatively until desufflation.

干预措施: Lidocaine (Drug)

Control group

Placebo Comparator

Intravenous sodium chloride 0.9% solution volume matched in bolus and infusion.

干预措施: sodium chloride 0.9% solution (Drug)

结局指标

主要结局

Optic Nerve Sheath Diameter (ONSD)

时间窗: 5 min before induction of anesthesia till 5 min after the closure of pneumoperitoneum

ONSD at 5 min before induction of anesthesia in supine position (T1), 5 min after CO2 pneumoperitoneum in Trendelenburg position (T2), 30 min after CO2 pneumoperitoneum in Trendelenburg position (T3), 60 min after CO2 pneumoperitoneum in Trendelenburg position (T4) and 5 min after the closure of pneumoperitoneum in supine position (T5).

次要结局

  • Heart rate(5 min before induction of anesthesia till 5 min after the closure of pneumoperitoneum)
  • Mean arterial blood pressure(5 min before induction of anesthesia till 5 min after the closure of pneumoperitoneum)
  • The incidence of postoperative adverse reactions(Within 3 hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Osama Rehab

Lecturer of Anesthesiology, Intensive Care and Pain Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验

Lidocaine Infusion on Optic Nerve Sheath Diameter in... | 临床试验